HOUSTON, Aug. 21, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.
Rohan Hoare, Cyberonics' Chief Operating Officer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York on Tuesday, September 9, 2014 at 3:30 PM Eastern Time. The conference will be conducted in an "unplugged" format, with presentations limited to verbal remarks only. The session will not be webcast.
Greg Browne, Cyberonics' Chief Financial Officer, will present at the Credit Suisse 5th Annual Small and Mid Cap Conference in New York on Wednesday, September 17, 2014 at 10:10 AM Eastern Time. The format for this conference is an informal group meeting followed by a question and answer session. No slides will be presented, and the group meeting will not be webcast.
About Cyberonics, Inc. and the VNS Therapy® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.
Greg Browne, CFO
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262 / Fax: (281) 218-9332
SOURCE Cyberonics, Inc.